Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for SONVF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SONVF and 80,000+ other tickers.
See exactly how SONVF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SONVF and 80,000+ other tickers.
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and…
Sonova launched its third hearing-aid platform utilising real-time AI on Monday, its latest effort to strengthen its position in a market that relies on rapid technology upgrades to shorten replacement cycles and attract first-time users.
Sonova Holding AG (SONVY) Q4 2026 Earnings Call Transcript
Sonova Holding AG (SONVY) Discusses Refreshed Strategy and Vision for Next Phase of Growth Transcript
Sonova's full year revenue will come at the lower end of its 2025/2026 forecast range for growth of 5% to 9%, hearing-aid maker CEO Eric Bernard said in an interview published on Friday.
Sonova Holding AG (OTCPK:SONVY) Q2 2026 Earnings Call November 14, 2025 7:00 AM EST Company Participants Thomas Bernhardsgruetter - Senior Director of Investor Relations Eric Bernard - CEO & Interim GVP of Hearing Instruments Elodie Carr-Cingari - Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Bank PLC, Research Division Andjela Bozinovic - BNP Paribas, Research Division Veronika Dubajova - Citigroup Inc., Research Division Oliver Metzger - ODDO BHF Corporate & Markets, Research Division Urs Kunz - Research Partners AG Martinien Rula - Jefferies LLC, Research Division Susannah Ludwig - Sanford C. Bernstein & Co., LLC.